Chiral analysis of methadone and its main metabolite EDDP in postmortem blood by liquid chromatography-mass spectrometry

Journal of Analytical Toxicology

Volumn 32, Issue 7, 2008, Pages 499-504

  Johansen, Sys Stybe ^a,b   Linnet, Kristian ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Permanent address: Frederik V's Vej 11   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

2 ETHYL 1,5 DIMETHYL 3,3 DIPHENYLPYRROLINIUM; ACETIC ACID DERIVATIVE; ACETONITRILE; AMMONIUM ACETATE; BUTYL ACETATE; DRUG METABOLITE; METHADONE; SODIUM HYDROXIDE; WATER;

ARTICLE; BLOOD; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETER; MASS SPECTROMETRY; PLASMA;

EID: 50949101198     PISSN: 01464760     EISSN: 01464760     Source Type: Journal    
DOI: 10.1093/jat/32.7.499     Document Type: Article

References (20)

1. K. Kristensen, T. Blemmer, H.R. Angelo, L.L. Christrup, N.E. Drenck, S.N. Rasmussen, and P. Sjogren. Stereoselective pharmacokinetics of methadone in chronic pain patients. Ther. Drug Monit. 18: 221-227 (1996).
2. C.B. Eap, T. Finkbeiner, M. Gastpar, N. Scherbaum, K. Powell, and P. Baumann. Replacement of (R)-methadone by a double dose of (R,S)-methadone in addicts: interindividual variability of the (R)/(S) ratios and evidence of adaptive changes in methadone pharmacokinetics. Eur. J. Clin. Pharmacol. 50: 385-389 (1996).
3. D.J.R. Foster, A.A. Somogyi, K.R. Dyer, J.M. White, and F. Bochner. Steady-state pharmacokinetics of (R)- and (S)-methadone in methadone maintenance patients. Br. J. Clin. Pharmacol. 50: 427-440 (2000).
4. S. Souverain, C. Eap, J.L. Veuthey, and S. Rudaz. Automated LC-MS method for the fast stereoselective determination of methadone in plasma. Clin. Chem. Lab. Med. 41: 1615-1621 (2003).
5. T.B. Mitchell, K.R. Dyer, D. Newcombe, A. Salter, A.A. Somogyi, F. Bochner, and J.M. White. Subjective and physiological responses among racemic-methadone maintenance patients in relation to relative (S)- vs. (R)-methadone exposure. Br. J. Clin. Pharmacol. 58: 609-617 (2004).
6. M.E. Rodriguez-Rosas, J.G. Medrano, D.H. Epstein, E.T. Moolchan, K.L. Preston, and I.W. Wainer. Determination of total and free concentrations of the enantiomers of methadone and its metabolite in human plasma by enantioselective liquid chromatography with mass spectrometric detection. J. Chromatogr. A 1073: 237-248 (2005).
7. 2, δ, κ opioid receptor binding profiles of methadone stereoisomers and morphine. Life Sci. 56: 45-50 (1995).
8. J.M. Corkery, F. Schifano, A. Hamid Ghodse, and A. Oyefeso. The effects of methadone and its role in fatalities. Hum. Psychopharmacol. Clin. Exp. 19: 565-576 (2004).
9. A. Steentoft. B. Kringsholm, A.C. Hansen, D. Rollmann, K.W. Simonsen, I.B. Müller, S.S. Johansen, H.W. Petersen, and A.P.F. Petersen. Fatal poisonings among drug addicts in Denmark in 2002. Ugeskr. Læger 167: 1954-1957 (2005) (in Danish).
10. S.S. Johansen. C. Jakobsen, I.B. Müller, H.W. Petersen, K.W. Simonsen, B. Kringsholm, and A. Steentoft. Fatal cases of poisoning in eastern Denmark during a five-year period (1998-2002). Ugeskr. Læger 168: 3326-3331 (2006).
11. S.S. Johansen. Quantification of methadone in forensic samples by LC-MS-MS. TIAFT Proceedings, Prague, Czech Republic, 2001, pp 412-415.
12. International Organization for Standardization (ISO). ISO 17025: General requirements for the competence of calibration and testing laboratories. Geneva, Switzerland, 2005.
13. F.T. Peters, O.H. Drummer, and F. Musshoff. Validation of new methods. Forensic Sci. Int. 165: 216-224 (2007).
14. V.P. Shah, K.K. Midha, J.W.A. Findlay, H.M. Hill, J.D. Hulse, I.J. McGilveray, G. McKay, K.J. Miller, R.N. Patnaik, M.L. Powell, A. Tonelli, C.T. Viswanathan, and A. Yacobi. Bioanalytical method validation - a revisit with a decade of progress. Pharmaceut. Res. 17: 1551-1557 (2000).
15. M. Schulz and A. Schmoldt. Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics. Pharmazie 58: 447-474 (2003).
16. R.A. Totah, K.E. Allen, P. Sheffels, D. Whittington, and E.D. Kharasch. Enantiomeric metabolic interactions and stereoselective human methadone metabolism. J. Pharmacol. Exp. Ther. 321: 389-399 (2007).
17. C.E. Inturrisi, W.A. Colburn, R.F. Kaiko, R.W. Houde, and K.M. Foley. Pharmacokinetics and pharmacodynamics of methadone in patients with chronic pain. Clin. Pharmacol. Ther. 41: 392-401 (1987).
18. R.W. Prouty and W.H. Anderson. The forensic science implications of site and temporal influences on postmortem blood-drug concentrations. J. Forensic Sci. 35: 243-270 (1990)
19. B. Levine, S.C. Wu, A. Dixon, and J.E. Smialek. Site dependence of postmortem blood methadone concentrations. Am. J. Forensic Med. Pathol. 16: 97-100 (1995).
20. K. Verebely, J. Volavka, S. Mule, and R. Resnick. Methadone in man: pharmacokinetic and excretion studies in acute and chronic treatment. Clin. Pharmacol. Ther. 18: 180-190 (1975).